"My goal is to have my patients feel the warmth of my true concern for their health."

During the past decade, Marilyn Norton, M. D. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Marilyn Norton, M. D." are "Ovarian Neoplasms" (2 trials) and "Non Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Marilyn Norton, M. D." in a lesser frequency.

Most popular intervention types in "Marilyn Norton, M. D." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Doxorubicin HCl Liposome Injection" (1 trials), "TLK286 (Telcyta) HCl for Injection" (1 trials), "TLK286 HCl for injection" (1 trials), "TLK286 in Combination with Carboplatin" (1 trials) and "doxorubicin HCl liposome injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marilyn Norton, M. D." are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Marilyn Norton, M. D.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Marilyn Norton, M. D., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marilyn Norton, M. D., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".